Company: HURA
Filing Date: 2025-06-12
Form Type: 8-K
Source: 0000950170-25-085116
Chunk: 0

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-06-12
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 6, 2025, the Compensation Committee (the “ Committee”) of the Board of Directors (the “ Board”) of TuHURA Biosciences, Inc. (the “ Company”) approved an increase to the annual base salaries of James A. Bianco, M. D., Chief Executive Officer, as well as Dan Dearborn, Chief Financial Officer, to $577,101 and $384,453, respectively, with such increase to be effective as of June 6, 2025. In approving the base salary changes for Mr. Bianco and Mr. Dearborn, the Committee considered, among other factors, the compensation practices, trends and data from the Company’s compensation peer group, consisting of comparable companies as identified by the Committee and an independent compensation consultant engaged by the Committee, with the resulting adjustment putting Mr. Bianco’s and Mr. Dearborn’s base salary level at approximately 90% of the 50 th percentile of base salary levels for the peer group.

Summary Compensation - Fiscals 2024 and 2023

On February 7, 2024, the Company’s filed a Registration Statement on Form S-4, of which proxy statement/prospectus of the Company was made part, as amended (Registration No. 333-284787) (the “ Proxy Statement”). Pursuant to Instruction 1 to Item 402(n)(2)(iv) of Regulation S-K, the Company omitted from the Summary Executive Compensation Table included in the Proxy Statement annual incentive bonuses for its 2024 fiscal year for the individuals who served as the Company’s principal executive officer and principal financial officer (the “ Named Executive Officers”), and stated in such Form S-4 that the Company would provide an updated Summary Compensation Table following such determination.

On June 6, 2025, the Committee approved fiscal year 2024 annual incentive bonuses for the Named Executive Officers. In accordance with Item 5.02(f) of Form 8-K, the Company is providing a revised Summary Compensation Table, which includes the actual value of the 2024 annual incentive bonus awards earned by each of the Company’s Named Executive Officers under the heading “ Bonus” and revised total compensation figures for fiscal year 2024:

  Name and Principal Position         Fiscal year       Salary      Bonus (1)      Stock Awards ($)      Option Awards (2)